What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
His scientific interests lie mostly in Human leukocyte antigen, Immunology, MHC class I, Antigen and Molecular biology.
Francisco Ruiz-Cabello interconnects Cancer research, Melanoma, Pathology, Loss of heterozygosity and Major histocompatibility complex in the investigation of issues within Human leukocyte antigen.
Francisco Ruiz-Cabello has researched Melanoma in several fields, including Cytotoxic T cell and Immunotherapy.
His Immunology study integrates concerns from other disciplines, such as Downregulation and upregulation and Metastasis.
His MHC class I research focuses on subjects like Lymphokine-activated killer cell, which are linked to CD30, HLA-E, Cell and NK-92.
The Molecular biology study combines topics in areas such as Cell culture, Virus, DNA sequencing, Monoclonal antibody and Polymerase chain reaction.
His most cited work include:
- IMPLICATIONS FOR IMMUNOSURVEILLANCE OF ALTERED HLA CLASS I PHENOTYPES IN HUMAN TUMOURS (674 citations)
- Natural history of HLA expression during tumour development (401 citations)
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury is Influenced by Multiple HLA Class I and II Alleles (317 citations)
What are the main themes of his work throughout his whole career to date?
Francisco Ruiz-Cabello focuses on Human leukocyte antigen, Immunology, Antigen, Molecular biology and Pathology.
The concepts of his Human leukocyte antigen study are interwoven with issues in Cancer research, Melanoma, MHC class I, Major histocompatibility complex and Loss of heterozygosity.
His Immunology research focuses on Cytotoxic T cell and how it relates to Tumor microenvironment.
His work in Antigen addresses issues such as Monoclonal antibody, which are connected to fields such as Virology.
His Molecular biology research integrates issues from Cell culture, Cell and Mutation, Gene expression, Gene.
His research on Pathology often connects related areas such as Cancer.
He most often published in these fields:
- Human leukocyte antigen (50.26%)
- Immunology (44.10%)
- Antigen (31.28%)
What were the highlights of his more recent work (between 2012-2021)?
- Human leukocyte antigen (50.26%)
- Immunology (44.10%)
- Cancer research (16.92%)
In recent papers he was focusing on the following fields of study:
Human leukocyte antigen, Immunology, Cancer research, Immune system and Cytotoxic T cell are his primary areas of study.
His work deals with themes such as T cell, Antigen presentation, Loss of heterozygosity and Immunotherapy, which intersect with Human leukocyte antigen.
His Immunology study combines topics in areas such as Haplotype, Liver injury and Drug.
His studies deal with areas such as Bladder cancer, Cancer cell and Major histocompatibility complex as well as Cancer research.
His study in Immune system is interdisciplinary in nature, drawing from both Infiltration and Pathology.
His study explores the link between Cytotoxic T cell and topics such as Tumor microenvironment that cross with problems in MHC class I, Tumor-infiltrating lymphocytes, CTL* and Peripheral blood mononuclear cell.
Between 2012 and 2021, his most popular works were:
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma. (87 citations)
- Rejection versus escape: the tumor MHC dilemma (66 citations)
- HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. (61 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
Francisco Ruiz-Cabello mostly deals with Human leukocyte antigen, Immunology, Immune system, Infiltration and Pathology.
His Human leukocyte antigen study incorporates themes from Phenotype, T cell, Immunotherapy, Cancer immunotherapy and Loss of heterozygosity.
His Loss of heterozygosity research is multidisciplinary, incorporating perspectives in Primary tumor and Melanoma.
His research in Immunology intersects with topics in Bilirubin, Cytotoxic T cell and Allele, Haplotype.
His Immune system research is multidisciplinary, incorporating elements of Cancer research and Stromal cell.
When carried out as part of a general Pathology research project, his work on Lymphoma is frequently linked to work in Plasmacytoid dendritic cell, therefore connecting diverse disciplines of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
